Historical pg News Stories
P&G Moves: Filters, CEO Exit, Q4 Margins
This week P&G announced a Febreze cabin-filter licensing deal, a senior Health Care executive retirement, a Downy sports partnership, and mixed Q4 FY2025 results showing margin pressure offset by productivity—developments that could influence PG stock ahead of January earnings.
PG Slides Then Rebounds: Dow-Driven Volatility Now
Procter & Gamble shares fell $4.15 (−2.9%) on Dec 8, 2025, then recovered $1.71 (+1.2%) on Dec 9, 2025. The moves were driven by Dow-wide sentiment rather than any new, category-specific developments across Beauty, Grooming, Health Care, Fabric & Home Care, or Baby & Feminine Care. Investors should monitor upcoming earnings, retail demand signals, commodity costs, and promotional cadence for clearer operational cues.
P&G Shares Slide to Two-Year Low After Volume Drop
Procter & Gamble shares hit a two-year low after the CFO reported soft volumes in October and November tied to port disruptions, delayed SNAP benefits and consumer caution. Premium brands showed resilience while lower-income shoppers shifted toward value options, signaling pressure across Fabric & Home Care and Baby, Feminine & Family Care. This article breaks down the causes, segment impacts (Tide, Pampers, beauty/grooming) and the near-term implications for investors.
PG Stock Rises: Aussie Curl-Care Boosts Momentum!!
Recent late‑November moves put Procter & Gamble in focus: a new Aussie curl‑care launch and upbeat analyst coverage coincided with short‑term share gains, a modest pullback, a legal packaging suit moving forward, and a strategic debt raise — all factors shaping near‑term investor sentiment.
P&G Q2 Strength: Sales Lift Health, Home & Family
Procter & Gamble’s Q2 results show steady organic growth across grooming, health care, fabric & home care, and baby/family care. Maintained FY25 guidance and analyst support (UBS Buy, $176 target) reinforce PG’s defensive appeal for investors.
P&G Earnings Beat, Stock Drops to 52-Week Low Now!
Procter & Gamble reported a fiscal Q1 earnings beat and strong cash flow, yet its stock hit a 52-week low after investor reaction to macro uncertainty and near-term category softness. The company’s cost cuts and share-return program remain key catalysts for longer-term upside.
P&G Q1 Beats; Tariffs Cut FY26 EPS; Stock Holds Up
Procter & Gamble reported Q1 FY2026 results with modest top-line growth, stronger EPS and resilient cash flow, while tariffs and commodity costs shave about $0.39 off FY26 EPS. Management maintained full-year guidance amid an ongoing restructuring and a planned CEO transition.